ASTH

ASTH

USD

Astrana Health Inc. Common Stock

$26.360-0.290 (-1.088%)

Reaalajas hind

Healthcare
Medical Care Facilities
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$26.650

Kõrge

$27.380

Madal

$26.350

Maht

0.12M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

1.2B

Tööstusharu

Medical Care Facilities

Riik

United States

Kauplemisstatistika

Keskmine maht

0.29M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $23.12Praegune $26.360Kõrge $63.2

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 6. juuni 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

ASTH: Astrana Health Inc. Common Stock – Decoding Recent Trends and Future Signals

Stock Symbol: ASTH Generate Date: 2025-06-06 21:40:26

Let's break down what's happening with Astrana Health, Inc. (ASTH) right now. We'll look at the latest news, how the stock price has been moving, and what the AI models are hinting at for the near future.

Recent News Buzz: Investor Spotlight

Astrana Health recently announced they'll be participating in an upcoming investor conference. This kind of news usually brings a positive vibe. Why? Because it means the company is actively engaging with investors, looking to share their story, and potentially attract new capital or boost confidence in existing shareholders. It's a chance for them to highlight their strengths and future plans. The AI's sentiment analysis on this news is highly positive, scoring it very high, which suggests the market generally views these events favorably.

Price Check: A Recent Dip After a Climb

Looking at the past few months, ASTH had a pretty good run, climbing from the high $20s in March to the mid-$30s by mid-April. That's a solid upward trend. However, things have shifted more recently. Since early May, the stock has seen a noticeable pullback, dropping from around $32 to the current price of $25.26. This recent downward movement is quite clear, with the stock finding itself closer to its 52-week low ($23.12) than its high ($63.2). Volume has also been a bit lower lately compared to earlier in the year, though the recommendation data points to a recent surge in trading volume, which is interesting.

Outlook & Ideas: What the Data Suggests

Putting it all together, we have a bit of a mixed bag, but with some intriguing signals.

The recent news about the investor conference is a positive sign, indicating proactive management. This aligns with the AI's strong positive sentiment score for the news.

Now, let's talk about the price. The stock has pulled back significantly from its April highs. This could be seen as a correction or a cooling-off period. However, the AI's predictions are quite bullish for the very near term:

  • Today's Prediction: +0.72%
  • Next Day's Prediction: +2.39%
  • The Day After Next: +3.78%

These are notable predicted increases, especially considering the recent price action. The AI model also shows high confidence in its forecast and even projects a potential target price of $40.14 in the medium term. This suggests the AI sees the recent dip as a potential buying opportunity before a rebound.

So, what does this mean for potential strategy?

Given the positive news sentiment, the AI's confident upward predictions, and the stock currently sitting at a lower price point after a significant drop, the situation seems to lean towards potential buyers.

  • Potential Entry Consideration: If you're considering this stock, the current price around $25.00 - $25.26 might be an area to watch. The AI's suggested entry points are $24.83 and $24.98, which are right in this ballpark. This level is near recent support and aligns with the idea that the stock might be oversold after its recent decline.
  • Potential Exit/Stop-Loss Consideration: For managing risk, a stop-loss around $22.30 could be considered. This is below the recent 52-week low and would help limit potential losses if the downward trend continues unexpectedly. On the upside, the AI suggests a take-profit target of $26.51 in the short term, aligning with its immediate upward predictions. For a medium-term view, the AI's projected $40.14 target is much higher, suggesting significant room for growth if its longer-term outlook plays out.

Company Context: Healthcare Focus

Astrana Health operates in the Medical Care Facilities sector, providing healthcare management services. They work with various insurance types, including Medicare and Medicaid. This means their business is tied to the broader healthcare landscape and government policies. The company has seen strong revenue growth (53.4%), which is a big positive, but its Return on Equity is a bit low, and its debt-to-equity ratio is on the higher side. These are important factors to keep in mind for the long haul, even as the short-term signals look interesting.


Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Stock market investments involve risks, and past performance is not indicative of future results. Always conduct your own thorough research and consult with a qualified financial professional before making any investment decisions.

Seotud uudised

PR Newswire

Astrana Health, Inc. to Participate in Upcoming Investor Conference

Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading...

Vaata rohkem
Astrana Health, Inc. to Participate in Upcoming Investor Conference

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 12. juuni 2025, 11:47

LangevNeutraalneTõusev

71.8% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
Kasv
Kauplemisjuhend

Sisenemispunkt

$26.70

Võta kasum

$28.32

Peata kahjum

$23.72

Põhitegurid

RSI 24.2 viitab ülemüüdud tingimustele, mis viitab potentsiaalsele tugevale tagasipööramisele
DMI näitab langustrendi (ADX:21.9, +DI:6.0, -DI:18.6), mis viitab ettevaatlikkusele
Praegune hind on tugitasemele ($26.58) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 9.6x keskmisest (3,094), mis viitab äärmiselt tugevale ostusurvele
MACD -0.1044 on signaalijoone -0.0712 all, mis viitab langevale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.